Exploring a new way to deliver radiation therapy that minimizes damage to healthy tissues.
Official title: Treatment Planning System for Electron FLASH radiation therapy
Funded at University of Missouri-Columbia · NIH-11287489 · Data updated 2026-11-12
This study is exploring a new type of radiation therapy called FLASH radiotherapy, which gives a quick burst of high radiation to help treat tumors while causing less harm to healthy tissues, with the hope of making cancer treatments safer and more effective for patients like you.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | February 6, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $56,026 |
| NIH project number | 7R21CA277420-02 |
| Project ID | NIH-11287489 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research would be cancer patients who require radiation therapy and are at risk of significant normal tissue damage.
✕Less likely to help
Patients who are not undergoing radiation therapy or those with conditions that do not involve radiation treatment may not benefit from this research.
What this research studies
This research investigates a novel approach to radiation therapy known as FLASH radiotherapy, which delivers ultra-high dose rates of radiation. The goal is to reduce damage to normal tissues while effectively targeting tumors, potentially improving treatment outcomes for cancer patients. By optimizing treatment plans for larger animals and humans, the research aims to demonstrate the advantages of FLASH-RT over conventional radiation therapy. This could lead to safer and more effective cancer treatments in the future.
Why it matters
Potential benefit: If successful, this research could significantly reduce side effects from radiation therapy, improving the quality of life for cancer patients.
How similar studies have gone: While FLASH radiotherapy is a relatively novel approach, preliminary studies have shown promising results in reducing tissue damage compared to traditional methods.
Where this research is happening
-
University of Missouri-Columbia
Columbia, United States Active
Researchers
- Principal investigator: Zhang, Rongxiao — University of Missouri-Columbia
- Study coordinator: Zhang, Rongxiao
Related research
Other NIH-funded projects on the same topics.
-
Protecting small blood vessels from radiation by boosting mitochondrial health
It aims to prevent radiation-related damage to tiny blood vessels and reduce later thinking and memory problems in people who get radiation therapy by protecting cell mitochondria.
-
Proton SBRT for refractory ventricular tachycardia with real-time 3D/4D imaging
A patient-facing study exploring a proton-based, noninvasive radiation therapy to treat stubborn VT using advanced 3D and 4D imaging to target the heart safely.
-
Embedding symptom support in radiation therapy for prostate cancer
A multi-site study tests whether delivering mindfulness-based symptom support right inside radiation therapy is feasible and acceptable for men with prostate cancer.
-
Targeting SREBP2 to boost radiation therapy in HPV-negative head and neck cancer
This grant aims to see if blocking SREBP2 can make radiation therapy work better for people with HPV-negative Head and Neck Squamous Cell Carcinoma.
-
Genetic and Immune Factors in Squaring the Room: Sacituzumab plus Radiation for Bladder Cancer
A study aims to understand why combining sacituzumab with radiation helps some bladder cancer patients more than others, with the goal of making bladder-sparing therapy more effective.
-
CivaDerm: a new four-day skin cancer radiation bandage
A new four‑day radiation bandage for non-melanoma skin cancer aims to treat facial and other areas without multiple clinic visits or big scars.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.